Camilla Pesoni
Verona, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 17, 2023
Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab.
Journal: Journal of personalized medicine
Published: January 09, 2023
Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports.
Journal: Clinical drug investigation
Published: July 06, 2022
Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer.
Journal: Frontiers in surgery
Published: January 30, 2022
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion.
Journal: JCO precision oncology
Published: January 10, 2022
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: December 25, 2020
Targeting KRAS: The Elephant in the Room of Epithelial Cancers.
Journal: Frontiers in oncology
Published: December 06, 2020
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 22, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026